ArticleBJU international2019
Taxane-based chemohormonal therapy for metastatic hormone-sensitive prostate cancer: a Cochrane Review.
Niranjan J Sathianathen et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it